Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans

Genes and Immunity

Volumn 7, Issue 4, 2006, Pages 310-315

  Brassat, D ^a   Motsinger, Alison A ^b   Caillier, S J ^a   Erlich, H A ^c   Walker, K ^c   Steiner, L L ^c   Cree, B A C ^a   Barcellos, L F ^d   Pericak Vance, M A ^e   Schmidt, S ^e   Gregory, S ^e   Hauser, S L ^a   Haines, J L ^b   Oksenberg, J R ^a   Ritchie, M D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ROCHE MOLECULAR SYSTEMS   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 5 ANTIBODY;

ACCURACY; AFRICAN AMERICAN; ANTIBODY DETECTION; ARTICLE; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC EPISTASIS; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AFRICAN AMERICANS; ANTIGENS, CD14; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-5 RECEPTOR ALPHA SUBUNIT; MALE; MULTIFACTORIAL INHERITANCE; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-4;

EID: 33745044212     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364299     Document Type: Article

References (34)

1. Hauser SL, Goodin DS. Multiple sclerosis and other demyelinating diseases. In: Kasper DL, Braunwald E, Fauci AD, Hauser SL, Longo DL, Jameson JL (eds). Harrison's Principle of Internal Medicine, 16th edn, McGraw Hill: New York, 2005.
2. Oksenberg JR, Barcellos LF. Multiple sclerosis genetics: Leaving no stone unturned. Genes Immun 2005; 6: 375-387.
3. Haines JL, Ter-Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat Genet 1996; 13: 469-471.
4. Lincoln MR, Montpetit A, Cader MZ, Saarela J, Dyment DA, Tiislar M et al. A predominant role for the HLA class lI region in the association of the MHC region with multiple sclerosis. Nat Genet 2005; 37: 1108-1112.
5. Sawcer S, Ban M, Maranian M, Yeo TW, Compston A, Kirby A et al. A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 2005; 77: 454-467.
6. Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 2004; 74: 160-167.
7. Wallin MT, Page WF, Kurtzke JF. Multiple sclerosis in US veterans of the Vietnam era and later military service: Race, sex, and geography. Ann Neurol 2004; 55: 65-71.
8. Cree BA, Khan O, Bourdette D, Goodin DS, Cohen JA, Marrie RA et al. Clinical characteristics of African Americans versus Caucasian Americans with multiple sclerosis. Neurol 2004; 63: 2039-2045.
9. Cree BA, Al-Sabbagh A, Bennett R, Goodin D. Response to interferon Beta-1a treatment in African american multiple sclerosis patients. Arch Neurol 2005; 62: 1681-1683.
10. Reich D, Patterson N, De Jager PL, McDonald GJ, Waliszewska A, Tandon A et al. A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nat Genet 2005; 37: 1113-1118.
11. Traherne JA, Barcellos LF, Sawcer SJ, Compston A, Ramsay PP, Hauser SL et al. Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15. Hum Mol Genet 2006; 15: 155-161.
12. Haines JL, Pericak-Vance MA. Approaches to Gene Mapping in Complex Human Diseases. Wiley-Liss: New York, 1998.
13. Bellman R. Adaptive Control Processes. Princeton Princeton University Press, 1961.
14. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med 1993; 118: 201-210.
15. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996; 49: 1373-1379.
16. Moore JH, Williams SM. New strategies for identifying gene-gene interactions in hypertension. Ann Med 2002; 34: 88-95.
17. Ritchie MD, Hahn LW, Moore JH. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 2003; 24: 150-157.
18. Hahn L, Moore JH. Ideal discrimination of discrete clinical endpoints using multilocus genotypes. In Silico Biology 2004; 4: 0016.
19. Mirel DB, Barcellos LF, Wang J, Hauser SL, Oksenberg JR, Erlich HA. Analysis of IL4R haplotypes in predisposition to multiple sclerosis. Genes Immun 2004; 5: 138-141.
20. Suppiah V, Goris A, Alloza I, Heggarty S, Dubois B, Carton H et al. Polymorphisms in the interleukin-4 and IL-4 receptor genes and multiple sclerosis: A study in Spanish-Basque, Northern Irish and Belgian populations. Int J Immunogenet 2005; 32: 383-388.
21. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999; 17: 701-738.
22. Hulshof S, Montagne L, De Groot CJ, Van der Valk P. Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions. Glia 2002; 38: 24-35.
23. Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 1997; 337: 1720-1725.
24. Sandford AJ, Chagani T, Zhu S, Weir TD, Bai TR, Spinelli JJ et al. Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity. J Allergy Clin Immunol 2000; 106: 135-140.
25. Shirakawa I, Deichmann KA, Izuhara I, Mao I, Adra CN, Hopkin JM. Atopy and asthma: Genetic variants of IL-4 and IL-13 signaling. Immunol Today 2000; 21: 60-64.
26. Mirel DB, Valdes AM, Lazzeroni LC, Reynolds RL, Erlich HA, Noble JA. Association of IL4R haplotypes with type 1 diabetes. Diabetes 2002; 51: 3336-3341.
27. Huang YM, Xiao BG, Ozenci V, Kouwenhoven M, Teleshova N, Fredrikson S et al. Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines. J Neuroimmunol 1999; 99: 82-90.
28. Cravens PD, Lipsky PE. Dendritic cells, chemokine receptors and autoimmune inflammatory diseases. Immunol Cell Biol 2002; 80: 497-505.
29. Plumb J, Armstrong MA, Duddy M, Mirakhur M, McQuaid S. CD83-positive dendritic cells are present in occasional perivascular cuffs in multiple sclerosis lesions. Mult Scler 2003; 9: 142-147.
30. Larregina AT, Morelli AE, Kolkowski E, Sanjuan N, Barboza ME, Fainboim L. Pattern of cytokine receptors expressed by human dendritic cells migrated from dermal explants. Immunology 1997; 91: 303-313.
31. Parra EJ, Marcini A, Akey J, Martinson J, Batzer MA, Cooper R et al. Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet 1998; 63: 1839-1851.
32. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
33. Hahn LW, Moore JH. Ideal discrimination of discrete clinical endpoints using multilocus genotypes. In Silico Biol 2004; 4: 183-194.
34. Ritchie MD, Motsinger AA. Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studies. Pharmacogenomics 2005; 6: 823-834.